Clinical Trial Update: Ketones, Muscle Metabolism, and SGLT2 Inhibitors - Protocol 1 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial protocol evaluating ketones and muscle metabolism with SGLT2 inhibitors in patients with heart failure and type 2 diabetes mellitus; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Type 2 Diabetes Mellitus

Drugs mentioned

• Ketone therapy (exogenous ketones)
• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Heart Failure, Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2025-09-29